Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 7/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17083819 | 0.93 | ALDH1A1 (0.38) | ALDH1A1LMNATLR2CNR2PRKCA | |
| SCHEMBL17083808 | 0.92 | TRPV1 (0.38) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL17083810 | 0.92 | TLR2 (0.37) | ALDH1A1LMNATLR2CNR2 | |
| SCHEMBL17083878 | 0.88 | KMT2A (0.37) | ALDH1A1LMNACNR2MEN1HPGD | |
| SCHEMBL17083807 | 0.86 | PRKCA (0.40) | ALDH1A1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL17083811 | 0.86 | L3MBTL1 (0.38) | ALDH1A1MEN1HPGDKMT2ATBXAS1 | |
| SCHEMBL17083813 | 0.85 | TLR2 (0.41) | ALDH1A1LMNATLR2CNR2PRKCA | |
| SCHEMBL17083812 | 0.84 | TRPV1 (0.37) | TLR2PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL17083832 | 0.84 | TLR2 (0.40) | ALDH1A1LMNATLR2CNR2PRKCA | |
| SCHEMBL17083873 | 0.82 | KMT2A (0.39) | ALDH1A1LMNACNR2PRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328192-B2 | Bio-based monomers and polymers | BEZWADA BIOMEDICAL, LLC (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150259464-A1 | BIO-BASED MONOMERS AND POLYMERS | BEZWADA BIOMEDICAL, LLC | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259464-A1 | BIO-BASED MONOMERS AND POLYMERS | FHIT, MGAM, BPGM | ALDH1A1 1034/4885LMNA 3243/4885TLR2 1217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.